These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18426893)

  • 41. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension.
    Testa M; Yeh M; Lee P; Fanelli R; Loperfido F; Berman JW; LeJemtel TH
    J Am Coll Cardiol; 1996 Oct; 28(4):964-71. PubMed ID: 8837575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
    West M; Boulanger BR; Fogarty C; Tennenberg A; Wiesinger B; Oross M; Wu SC; Fowler C; Morgan N; Kahn JB
    Clin Ther; 2003 Feb; 25(2):485-506. PubMed ID: 12749509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of community-acquired pneumonia with levofloxacin: 500 mg once a day or 500 mg twice a day?].
    Zuck P; Bru JP
    Presse Med; 2000 May 27-Jun 3; 29(19):1062-5. PubMed ID: 10874918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of age on the systemic inflammatory response in patients with community-acquired pneumonia.
    van Vught LA; Endeman H; Meijvis SC; Zwinderman AH; Scicluna BP; Biesma DH; van der Poll T
    Clin Microbiol Infect; 2014 Nov; 20(11):1183-8. PubMed ID: 24930498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections.
    Bruunsgaard H; Skinhøj P; Qvist J; Pedersen BK
    J Infect Dis; 1999 Aug; 180(2):551-4. PubMed ID: 10395881
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Choice of antibiotic and risk of colonization with vancomycin-resistant Enterococcus among patients admitted for treatment of community-acquired pneumonia.
    Manzella J; Benenson R; Pellerin G; Kellogg J; Bell T; Robertson M; Pope D
    Infect Control Hosp Epidemiol; 2000 Dec; 21(12):789-91. PubMed ID: 11140916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of alcohol use disorders on pulmonary immune cell inflammatory responses to Streptococcus pneumoniae.
    Gaydos J; McNally A; Burnham EL
    Alcohol; 2019 Nov; 80():119-130. PubMed ID: 30195043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia.
    Norrby SR; Petermann W; Willcox PA; Vetter N; Salewski E
    Scand J Infect Dis; 1998; 30(4):397-404. PubMed ID: 9817522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The effect of gamma-hydroxybutyrate (GHB) on proinflammatory cytokine gene expression in coronary surgical procedures].
    Kleinschmidt S; Bauer M; Wanner G; Bussmann D; Ziegenfuss T; Menger MD; Larsen R
    Anaesthesist; 1998 Aug; 47(8):651-62. PubMed ID: 9770088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia.
    Vetter N; Cambronero-Hernandez E; Rohlf J; Simon S; Carides A; Oliveria T; Isaacs R;
    Clin Ther; 2002 Nov; 24(11):1770-85. PubMed ID: 12501873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial.
    Groeneveld GH; van der Reyden TJ; Joosten SA; Bootsma HJ; Cobbaert CM; de Vries JJC; Kuijper EJ; van Dissel JT
    J Antimicrob Chemother; 2019 Aug; 74(8):2385-2393. PubMed ID: 31106377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis--a randomized, clinical trial.
    Clark MA; Plank LD; Connolly AB; Streat SJ; Hill AA; Gupta R; Monk DN; Shenkin A; Hill GL
    Crit Care Med; 1998 Oct; 26(10):1650-9. PubMed ID: 9781721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
    Anzueto A; Niederman MS; Pearle J; Restrepo MI; Heyder A; Choudhri SH;
    Clin Infect Dis; 2006 Jan; 42(1):73-81. PubMed ID: 16323095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia.
    Mohler J; Azoulay-Dupuis E; Amory-Rivier C; Mazoit JX; Bédos JP; Rieux V; Moine P
    Intensive Care Med; 2003 May; 29(5):808-16. PubMed ID: 12665994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytokine responses differ by compartment and wasting status in patients with HIV infection and healthy controls.
    Abad LW; Schmitz HR; Parker R; Roubenoff R
    Cytokine; 2002 Jun; 18(5):286-93. PubMed ID: 12161104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dexamethasone downregulates the systemic cytokine response in patients with community-acquired pneumonia.
    Remmelts HH; Meijvis SC; Biesma DH; van Velzen-Blad H; Voorn GP; Grutters JC; Bos WJ; Rijkers GT
    Clin Vaccine Immunol; 2012 Sep; 19(9):1532-8. PubMed ID: 22855392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Levofloxacine for the treatment of pneumococcal pneumonia: results of a meta-analysis].
    Bru JP; Leophonte P; Veyssier P
    Rev Pneumol Clin; 2003 Dec; 59(6):348-56. PubMed ID: 14745340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protection of blood brain barrier integrity and modulation of inflammatory mediators during treatment of pneumococcal meningitis with daptomycin or ceftriaxone.
    Barichello T; Goncalves JC; Generoso Jda S; Simoes LR; Tashiro MH; Goularte Jde A; Vuolo F; Rodrigues DH; Vilela MC; Petronilho F; Teixeira AL; Quevedo J
    Curr Neurovasc Res; 2014; 11(3):210-22. PubMed ID: 24845856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can the interleukin-1 receptor antagonist (IL-1ra) be a marker of anti-inflammatory response to enteral immunonutrition in malnourished patients after pancreaticoduodenectomy?
    Slotwinski R; Olszewski WL; Slotkowski M; Lech G; Zaleska M; Slotwinska SM; Krasnodebski WI
    JOP; 2007 Nov; 8(6):759-69. PubMed ID: 17993728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.